{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:16:17Z","timestamp":1789823777139,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Circulating microparticles (MPs) are major mediators in cardiovascular complications of type 2 diabetes (T2D); however, their contribution to Charcot foot (CF) disease is not known. Here, we purified and assessed the origin, concentration and content of circulating MPs from 33 individuals: 11 with T2D and acute CF, 11 T2D patients with equivalent neuropathy and 11 non-diabetic controls. First, we demonstrated that there were no differences in the distribution of MPs of endothelial, platelet origin among the 3 groups. However, MPs from leukocytes and monocytes origin were increased in CF patients. Moreover, we demonstrated that monocytes-derived MPs originated more frequently from intermediate and non-classical monocytes in CF patients. Five cytokines (G-CSF, GM-CSF, IL-1-ra, IL-2 and IL-16) were significantly increased in MPs from acute CF patients. Applying ingenuity pathways analysis, we found that those cytokines interacted well and induced the activation of pathways that are involved in osteoclast formation. Further, we treated THP-1 monocytes and monocytes sorted from healthy patients with CF-derived MPs during their differentiation into osteoclasts, which increased their differentiation into multinucleated osteoclast-like cells. Altogether, our study suggests that circulating MPs in CF disease have a high content of inflammatory cytokines and could increase osteoclast differentiation\n                    <jats:italic>in vitro<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-16365-7","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T11:38:47Z","timestamp":1511264327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction"],"prefix":"10.1038","volume":"7","author":[{"given":"Jennifer","family":"Pasquier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binitha","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hoarau-V\u00e9chot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Robay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Chidiac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha R.","family":"Dargham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebal","family":"Turjoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Halama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Fakhro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Jayyousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Rafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayaz A.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Talal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Abi Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"key":"16365_CR1","doi-asserted-by":"crossref","unstructured":"Larson, S. A. & Burns, P. R. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle \n                           3 (2012).","DOI":"10.3402\/dfa.v3i0.12236"},{"key":"16365_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1590\/2359-3997000000042","volume":"59","author":"MB Nobrega","year":"2015","unstructured":"Nobrega, M. B. et al. Risk factors for Charcot foot. Arch Endocrinol Metab \n                           59, 226\u2013230 (2015).","journal-title":"Arch Endocrinol Metab"},{"key":"16365_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2337\/dc09-1428","volume":"33","author":"J van Baal","year":"2010","unstructured":"van Baal, J., Hubbard, R., Game, F. & Jeffcoate, W. Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care \n                           33, 1086\u20131089 (2010).","journal-title":"Diabetes Care"},{"key":"16365_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2337\/diacare.18.1.34","volume":"18","author":"MJ Young","year":"1995","unstructured":"Young, M. J., Marshall, A., Adams, J. E., Selby, P. L. & Boulton, A. J. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care \n                           18, 34\u201338 (1995).","journal-title":"Diabetes Care"},{"key":"16365_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11892-014-0561-6","volume":"14","author":"JV Mascarenhas","year":"2014","unstructured":"Mascarenhas, J. V. & Jude, E. B. The Charcot foot as a complication of diabetic neuropathy. Curr Diab Rep \n                           14, 561 (2014).","journal-title":"Curr Diab Rep"},{"key":"16365_CR6","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers, L. C. et al. The Charcot foot in diabetes. Diabetes Care \n                           34, 2123\u20132129 (2011).","journal-title":"Diabetes Care"},{"key":"16365_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/dme.12590","volume":"32","author":"NL Petrova","year":"2015","unstructured":"Petrova, N. L. et al. Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy. Diabet Med \n                           32, 267\u2013273 (2015).","journal-title":"Diabet Med"},{"key":"16365_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2337\/dc09-1141","volume":"33","author":"L Uccioli","year":"2010","unstructured":"Uccioli, L. et al. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care \n                           33, 350\u2013355 (2010).","journal-title":"Diabetes Care"},{"key":"16365_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1101\/gad.192351.112","volume":"26","author":"C D\u2019Souza-Schorey","year":"2012","unstructured":"D\u2019Souza-Schorey, C. & Clancy, J. W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes & development \n                           26, 1287\u20131299 (2012).","journal-title":"Genes & development"},{"issue":"Suppl 1","key":"16365_CR10","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0049-3848(08)70020-3","volume":"122","author":"FD George","year":"2008","unstructured":"George, F. D. Microparticles in vascular diseases. Thromb Res \n                           122(Suppl 1), S55\u201359 (2008).","journal-title":"Thromb Res"},{"key":"16365_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.blre.2006.09.001","volume":"21","author":"A Piccin","year":"2007","unstructured":"Piccin, A., Murphy, W. G. & Smith, O. P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev \n                           21, 157\u2013171 (2007).","journal-title":"Blood Rev"},{"key":"16365_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00441-008-0710-9","volume":"335","author":"GN Chironi","year":"2009","unstructured":"Chironi, G. N. et al. Endothelial microparticles in diseases. Cell Tissue Res \n                           335, 143\u2013151 (2009).","journal-title":"Cell Tissue Res"},{"key":"16365_CR13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1615646","volume":"85","author":"RJ Berckmans","year":"2001","unstructured":"Berckmans, R. J. et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost \n                           85, 639\u2013646 (2001).","journal-title":"Thromb Haemost"},{"key":"16365_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2741\/1270","volume":"9","author":"LL Horstman","year":"2004","unstructured":"Horstman, L. L., Jy, W., Jimenez, J. J. & Ahn, Y. S. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci \n                           9, 1118\u20131135 (2004).","journal-title":"Front Biosci"},{"key":"16365_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1164\/rccm.201012-2061OC","volume":"184","author":"C Gordon","year":"2011","unstructured":"Gordon, C. et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med \n                           184, 224\u2013232 (2011).","journal-title":"Am J Respir Crit Care Med"},{"key":"16365_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/bja\/aes321","volume":"109","author":"VL Reid","year":"2012","unstructured":"Reid, V. L. & Webster, N. R. Role of microparticles in sepsis. Br J Anaesth \n                           109, 503\u2013513 (2012).","journal-title":"Br J Anaesth"},{"key":"16365_CR17","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.2337\/dc11-0844","volume":"34","author":"LC Rogers","year":"2011","unstructured":"Rogers, L. C. et al. The Charcot foot in diabetes. Diabetes Care \n                           34, 2123\u20132129 (2011).","journal-title":"Diabetes Care"},{"key":"16365_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2337\/diacare.17.6.557","volume":"17","author":"MJ Young","year":"1994","unstructured":"Young, M. J., Breddy, J. L., Veves, A. & Boulton, A. J. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care \n                           17, 557\u2013560 (1994).","journal-title":"Diabetes Care"},{"key":"16365_CR19","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.18632\/oncotarget.6677","volume":"7","author":"H Al Thawadi","year":"2016","unstructured":"Al Thawadi, H. et al. VE-cadherin cleavage by ovarian cancer microparticles induces beta-catenin phosphorylation in endothelial cells. Oncotarget \n                           7, 5289\u20135305 (2016).","journal-title":"Oncotarget"},{"key":"16365_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12307-013-0142-2","volume":"7","author":"J Pasquier","year":"2014","unstructured":"Pasquier, J. et al. Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation. Cancer Microenviron \n                           7, 41\u201359 (2014).","journal-title":"Cancer Microenviron"},{"key":"16365_CR21","doi-asserted-by":"publisher","first-page":"e112140","DOI":"10.1371\/journal.pone.0112140","volume":"9","author":"M Mandl","year":"2014","unstructured":"Mandl, M., Schmitz, S., Weber, C. & Hristov, M. Characterization of the CD14++ CD16+ monocyte population in human bone marrow. PloS one \n                           9, e112140 (2014).","journal-title":"PloS one"},{"key":"16365_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bone.2016.02.020","volume":"86","author":"F Loi","year":"2016","unstructured":"Loi, F. et al. Inflammation, fracture and bone repair. Bone \n                           86, 119\u2013130 (2016).","journal-title":"Bone"},{"key":"16365_CR23","doi-asserted-by":"publisher","first-page":"181849","DOI":"10.1155\/2013\/181849","volume":"2013","author":"H Kitaura","year":"2013","unstructured":"Kitaura, H. et al. Immunological reaction in TNF-alpha-mediated osteoclast formation and bone resorption in vitro and in vivo. Clinical & developmental immunology \n                           2013, 181849 (2013).","journal-title":"Clinical & developmental immunology"},{"key":"16365_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcmd.2015.05.009","volume":"55","author":"JM Mucci","year":"2015","unstructured":"Mucci, J. M. et al. Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology. Blood Cells Mol Dis \n                           55, 134\u2013143 (2015).","journal-title":"Blood Cells Mol Dis"},{"key":"16365_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.actbio.2013.09.028","volume":"10","author":"RS Hayden","year":"2014","unstructured":"Hayden, R. S., Vollrath, M. & Kaplan, D. L. Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films. Acta Biomater \n                           10, 486\u2013493 (2014).","journal-title":"Acta Biomater"},{"key":"16365_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1741826711409324","volume":"19","author":"C Abi Khalil","year":"2012","unstructured":"Abi Khalil, C., Roussel, R., Mohammedi, K., Danchin, N. & Marre, M. Cause-specific mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol \n                           19, 374\u2013381 (2012).","journal-title":"Eur J Prev Cardiol"},{"key":"16365_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/aps.2013.188","volume":"35","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Chen, L. M. & Liu, M. L. Microvesicles and diabetic complications\u2013novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacol Sin \n                           35, 433\u2013443 (2014).","journal-title":"Acta Pharmacol Sin"},{"key":"16365_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/107602960401000302","volume":"10","author":"S Nomura","year":"2004","unstructured":"Nomura, S. et al. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost \n                           10, 205\u2013215 (2004).","journal-title":"Clin Appl Thromb Hemost"},{"key":"16365_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000324383","volume":"31","author":"KH Jung","year":"2011","unstructured":"Jung, K. H. et al. Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles. Cerebrovasc Dis \n                           31, 485\u2013493 (2011).","journal-title":"Cerebrovasc Dis"},{"key":"16365_CR30","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.jacc.2005.02.047","volume":"45","author":"H Koga","year":"2005","unstructured":"Koga, H. et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol \n                           45, 1622\u20131630 (2005).","journal-title":"J Am Coll Cardiol"},{"key":"16365_CR31","doi-asserted-by":"crossref","unstructured":"Santilli, F. et al. Microparticles as new markers of cardiovascular risk in diabetes and beyond. Thrombosis and haemostasis \n                           116 (2016).","DOI":"10.1160\/TH16-03-0176"},{"key":"16365_CR32","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda, H. et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proceedings of the National Academy of Sciences of the United States of America \n                           95, 3597\u20133602 (1998).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"16365_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1160\/TH11-07-0500","volume":"106","author":"M Hristov","year":"2011","unstructured":"Hristov, M. & Weber, C. Differential role of monocyte subsets in atherosclerosis. Thromb. Haemost. \n                           106, 757\u2013762 (2011).","journal-title":"Thromb. Haemost."},{"key":"16365_CR34","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"KS Rogacev","year":"2012","unstructured":"Rogacev, K. S. et al. CD14++ CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J. Am. Coll. Cardiol. \n                           60, 1512\u20131520 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"16365_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. \n                           11, 762\u2013774 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"16365_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s00125-001-0772-7","volume":"45","author":"S Omoto","year":"2002","unstructured":"Omoto, S. et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia \n                           45, 550\u2013555 (2002).","journal-title":"Diabetologia"},{"key":"16365_CR37","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.4049\/jimmunol.0804314","volume":"183","author":"MS Lee","year":"2009","unstructured":"Lee, M. S. et al. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras\/ERK pathway. J Immunol \n                           183, 3390\u20133399 (2009).","journal-title":"J Immunol"},{"key":"16365_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jbmr.5650060912","volume":"6","author":"N Takahashi","year":"1991","unstructured":"Takahashi, N. et al. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res \n                           6, 977\u2013985 (1991).","journal-title":"J Bone Miner Res"},{"key":"16365_CR39","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood.V92.9.3465","volume":"92","author":"Y Takamatsu","year":"1998","unstructured":"Takamatsu, Y. et al. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood \n                           92, 3465\u20133473 (1998).","journal-title":"Blood"},{"key":"16365_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/jcp.24246","volume":"228","author":"S Li","year":"2013","unstructured":"Li, S. et al. A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem\/progenitor cells mobilization. J Cell Physiol \n                           228, 1002\u20131009 (2013).","journal-title":"J Cell Physiol"},{"key":"16365_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13047-015-0129-y","volume":"8","author":"A Folestad","year":"2015","unstructured":"Folestad, A. et al. Offloading treatment is linked to activation of proinflammatory cytokines and start of bone repair and remodeling in Charcot arthropathy patients. J Foot Ankle Res \n                           8, 72 (2015).","journal-title":"J Foot Ankle Res"},{"key":"16365_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1442-200X.2008.02561.x","volume":"50","author":"V Wiwanitkit","year":"2008","unstructured":"Wiwanitkit, V. Effect of interleukin-2 and tumor necrosis factor-alpha on osteopontin: molecular function and biological process. Pediatr Int \n                           50, 213\u2013215 (2008).","journal-title":"Pediatr Int"},{"key":"16365_CR43","first-page":"335","volume":"13","author":"GB Schneider","year":"1994","unstructured":"Schneider, G. B. & Relfson, M. Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats. Lymphokine Cytokine Res \n                           13, 335\u2013341 (1994).","journal-title":"Lymphokine Cytokine Res"},{"key":"16365_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.2041-1014.2010.00576.x","volume":"25","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol \n                           25, 275\u2013292 (2010).","journal-title":"Mol Oral Microbiol"},{"key":"16365_CR45","doi-asserted-by":"publisher","first-page":"917945","DOI":"10.1155\/2015\/917945","volume":"2015","author":"NL Petrova","year":"2015","unstructured":"Petrova, N. L., Petrov, P. K., Edmonds, M. E. & Shanahan, C. M. Inhibition of TNF-alpha Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy. J Diabetes Res \n                           2015, 917945 (2015).","journal-title":"J Diabetes Res"},{"key":"16365_CR46","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1464-5491.2011.03442.x","volume":"29","author":"A Korzon-Burakowska","year":"2012","unstructured":"Korzon-Burakowska, A. et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med \n                           29, 771\u2013775 (2012).","journal-title":"Diabet Med"},{"key":"16365_CR47","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.2337\/dc09-0243","volume":"32","author":"D Pitocco","year":"2009","unstructured":"Pitocco, D. et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study. Diabetes Care \n                           32, 1694\u20131697 (2009).","journal-title":"Diabetes Care"},{"key":"16365_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11892-015-0677-3","volume":"15","author":"J Pasquier","year":"2015","unstructured":"Pasquier, J., Hoarau-Vechot, J., Fakhro, K., Rafii, A. & Abi Khalil, C. Epigenetics and Cardiovascular Disease in Diabetes. Curr Diab Rep \n                           15, 108 (2015).","journal-title":"Curr Diab Rep"},{"key":"16365_CR49","first-page":"407","volume":"5","author":"F Paneni","year":"2015","unstructured":"Paneni, F. & Costantino, S. Diabetes and cardiovascular disease: let\u2019s push forward with translational research. Cardiovasc Diagn Ther \n                           5, 407\u2013411 (2015).","journal-title":"Cardiovasc Diagn Ther"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16365-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:17:54Z","timestamp":1671787074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16365-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["16365"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-16365-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]},"assertion":[{"value":"26 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16450"}}